Disclosed is the use of: a) a homeopathic activated-potentiated form of an antibody to brain-specific protein S-100 and b) a homeopathic activated-potentiated form of antibodies to endothelial NO synthase in the manufacture of a medicament for the treatment of attention deficit hyperactivity disorder.